Long-term olfactory dysfunction in COVID-19 patients: 18-month follow-up study.
作者信息
Ferreli Fabio, Gaino Francesca, Russo Elena, Di Bari Matteo, Rossi Vanessa, De Virgilio Armando, Di Stadio Arianna, Spriano Giuseppe, Mercante Giuseppe
机构信息
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Otorhinolaryngology-Head and Neck Surgery Unit, Humanitas Research Hospital-IRCCS, Rozzano, Milan, Italy.
出版信息
Int Forum Allergy Rhinol. 2022 Aug;12(8):1078-1080. doi: 10.1002/alr.22990. Epub 2022 Mar 9.
Abstract
摘要
相似文献
1
Long-term olfactory dysfunction in COVID-19 patients: 18-month follow-up study.新冠病毒感染患者的长期嗅觉功能障碍：18个月随访研究
Int Forum Allergy Rhinol. 2022 Aug;12(8):1078-1080. doi: 10.1002/alr.22990. Epub 2022 Mar 9.
2
Comparison of self-reported symptoms and psychophysical tests in coronavirus disease 2019 (COVID-19) subjects experiencing long-term olfactory dysfunction: a 6-month follow-up study.2019年冠状病毒病（COVID-19）长期嗅觉功能障碍患者自我报告症状与心理物理学测试的比较：一项6个月的随访研究。
Int Forum Allergy Rhinol. 2021 Nov;11(11):1592-1595. doi: 10.1002/alr.22828. Epub 2021 Jun 20.
3
The study of olfactory dysfunction in SARS-CoV-2 variants.新型冠状病毒变异株嗅觉功能障碍的研究。
Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5469-5470. doi: 10.1007/s00405-022-07548-8. Epub 2022 Jul 16.
4
Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.新型冠状病毒肺炎患者嗅觉障碍：嗅觉恢复的患病率和预后。
Otolaryngol Head Neck Surg. 2021 Jan;164(1):82-86. doi: 10.1177/0194599820943530. Epub 2020 Jul 14.
5
Olfactory Dysfunction in COVID-19 Patients Who Do Not Report Olfactory Symptoms: A Pilot Study with Some Suggestions for Dentists.新冠患者嗅觉障碍但无嗅觉症状：一项针对牙医的初步研究及建议
Int J Environ Res Public Health. 2022 Jan 18;19(3):1036. doi: 10.3390/ijerph19031036.
6
High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation.新冠病毒感染后患者长期嗅觉、味觉和化学感觉功能障碍的高发率：一项使用综合心理物理评估的为期一年的配对病例对照研究。
Rhinology. 2021 Dec 1;59(6):517-527. doi: 10.4193/Rhin21.249.
7
Six month follow-up of self-reported loss of smell during the COVID-19 pandemic.COVID-19 大流行期间自我报告嗅觉丧失的 6 个月随访。
Rhinology. 2021 Feb 1;59(1):26-31. doi: 10.4193/Rhin20.544.
8
Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.COVID-19 患者嗅觉功能障碍的六个月心理物理学评估。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab006.
9
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.288 例新冠病毒病嗅觉障碍患者的临床系列中嗅觉恢复的预测因素。
Eur J Neurol. 2021 Nov;28(11):3702-3711. doi: 10.1111/ene.14994. Epub 2021 Jul 9.
10
Trends in clinical trials for olfactory dysfunction in the COVID-19 era.新冠疫情时代嗅觉功能障碍临床试验的趋势。
Int Forum Allergy Rhinol. 2023 Oct;13(10):1958-1961. doi: 10.1002/alr.23144. Epub 2023 Mar 15.
引用本文的文献
1
Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19.评估不同生物分子在 COVID-19 预防和治疗中的补充作用。
Nutrients. 2024 Sep 11;16(18):3070. doi: 10.3390/nu16183070.
2
Maximizing Participation in Olfactory Training in a Sample with Post-COVID-19 Olfactory Loss.在新冠后嗅觉丧失样本中最大化嗅觉训练的参与度
Brain Sci. 2024 Jul 21;14(7):730. doi: 10.3390/brainsci14070730.
3
COVID-19-related chemosensory changes: Findings from a prospective national database.新型冠状病毒肺炎相关的化学感应变化：来自全国前瞻性数据库的研究结果
World J Otorhinolaryngol Head Neck Surg. 2024 Mar 26;10(2):97-104. doi: 10.1002/wjo2.164. eCollection 2024 Jun.
4
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.持续性 COVID-19 嗅觉异常和嗅觉训练后嗅觉丧失：比较中枢和外周作用治疗药物的随机临床试验。
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3671-3678. doi: 10.1007/s00405-024-08548-6. Epub 2024 Mar 16.
5
One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study.一项关于 COVID-19 引起的嗅觉障碍的为期一年的心理物理学评估：一项前瞻性队列研究。
BMC Med. 2023 Dec 8;21(1):490. doi: 10.1186/s12916-023-03205-x.
6
Effectiveness of platelet-rich plasma on post-COVID chronic olfactory dysfunction.富血小板血浆治疗新冠后慢性嗅觉功能障碍的效果。
Rev Assoc Med Bras (1992). 2023 Oct 27;69(11):e20230666. doi: 10.1590/1806-9282.20230666. eCollection 2023.
7
Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis.哮喘患者呼出气一氧化氮与嗅觉功能障碍：与慢性鼻-鼻窦炎的关系。
Medicina (Kaunas). 2023 Oct 5;59(10):1776. doi: 10.3390/medicina59101776.
8
Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.新冠患者的嗅觉功能恢复的主观感知与客观测量。
Viruses. 2023 Jun 23;15(7):1418. doi: 10.3390/v15071418.
9
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.嗅觉训练、棕榈酸乙醇酰胺和木樨草素或联合治疗 COVID-19 嗅觉功能障碍：一项盲法对照多中心随机试验。
Eur Arch Otorhinolaryngol. 2023 Nov;280(11):4949-4961. doi: 10.1007/s00405-023-08085-8. Epub 2023 Jun 28.
10
Evaluation of children and adults with post-COVID-19 persistent smell, taste and trigeminal chemosensory disorders: A hospital based study.新冠后持续性嗅觉、味觉和三叉神经化学感觉障碍的儿童及成人评估：一项基于医院的研究。
World J Clin Pediatr. 2023 Jun 9;12(3):133-150. doi: 10.5409/wjcp.v12.i3.133.
Zotero 插件